Literature DB >> 20029445

Explanations for worsening cancer survival.

Esther de Vries1, Henrike E Karim-Kos, Maryska L G Janssen-Heijnen, Isabelle Soerjomataram, Lambertus A Kiemeney, Jan Willem W Coebergh.   

Abstract

If cancer survival is reported to be worsening over time or inferior compared to other countries, politicians and health-care workers may get blamed because suboptimal care is presumed to be the cause. Yet, a variety of reasons exist for cancer survival statistics to change for the worse, of which deterioration of care is only one. Another explanation is that the improved diagnosis of premalignant lesions causes survival statistics to reflect only the most aggressive cancers-those with the poorest prognosis. In addition, deleterious changes in the distribution of prognostic factors and in the distribution of sociodemographic characteristics may negatively affect survival proportions. In this article, we identify the pitfalls that might be encountered in comparisons of published, population-based survival data from different time periods or populations.

Entities:  

Mesh:

Year:  2010        PMID: 20029445     DOI: 10.1038/nrclinonc.2009.184

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  28 in total

1.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

2.  How to interpret the relative survival ratios of cancer patients.

Authors:  Arun Pokhrel; Timo Hakulinen
Journal:  Eur J Cancer       Date:  2008-09-24       Impact factor: 9.162

3.  Socioeconomic inequalities in cancer survival in England and Wales.

Authors:  M P Coleman; P Babb; A Sloggett; M Quinn; B De Stavola
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

4.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

5.  Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery.

Authors:  L Ciccolallo; R Capocaccia; M P Coleman; F Berrino; J W W Coebergh; R A M Damhuis; J Faivre; C Martinez-Garcia; H Møller; M Ponz de Leon; G Launoy; N Raverdy; E M I Williams; G Gatta
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Laurén type and subsite.

Authors:  P S Pinheiro; L H van der Heijden; J W Coebergh
Journal:  Int J Cancer       Date:  1999-02-19       Impact factor: 7.396

7.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.

Authors:  Henrike E Karim-Kos; Esther de Vries; Isabelle Soerjomataram; Valery Lemmens; Sabine Siesling; Jan Willem W Coebergh
Journal:  Eur J Cancer       Date:  2008-02-14       Impact factor: 9.162

8.  Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.

Authors:  M L Janssen-Heijnen; J W Coebergh
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

9.  Recent major progress in long-term cancer patient survival disclosed by modeled period analysis.

Authors:  Hermann Brenner; Adam Gondos; Volker Arndt
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

10.  The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.

Authors:  Erica H Lambert; Phillip M Pierorazio; Carl A Olsson; Mitchell C Benson; James M McKiernan; Steven Poon
Journal:  BJU Int       Date:  2007-07       Impact factor: 5.588

View more
  2 in total

1.  A further caveat in interpreting cancer survival.

Authors:  Stefano Rosso; Roberto Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2010-04       Impact factor: 66.675

2.  Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.

Authors:  Yasuhiro Fujisawa; Shusuke Yoshikawa; Akane Minagawa; Tatsuya Takenouchi; Kenji Yokota; Hiroshi Uchi; Naoki Noma; Yasuhiro Nakamura; Jun Asai; Junji Kato; Susumu Fujiwara; Satoshi Fukushima; Jiro Uehara; Toshihiko Hoashi; Tatsuya Kaji; Taku Fujimura; Kenjiro Namikawa; Manabu Yoshioka; Naoki Murao; Dai Ogata; Kanako Matsuyama; Naohito Hatta; Yoshitsugu Shibayama; Toshiharu Fujiyama; Masashi Ishikawa; Daisuke Yamada; Akiko Kishi; Yoshiyuki Nakamura; Takatoshi Shimiauchi; Kazuyasu Fujii; Manabu Fujimoto; Hironobu Ihn; Norito Katoh
Journal:  Cancer Med       Date:  2019-04-01       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.